Companies Dominating the Biosensors Landscape
- Bio-Rad Laboratories Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Abbott Laboratories
- Medtronic
- LifeScan, Inc.
- QTL Biodetection LLC
- Molecular Devices Corp.
- Nova Biomedical
- Molex LLC
- Biosensors International Group, Ltd.
- Pinnacle Technologies Inc.
- DuPont Biosensor Materials
- Johnson & Johnson
- Zimmer & Peacock AS
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
Currently in 2025, the industry revenue of biosensors is estimated at USD 33.17 billion.
The global biosensors market is anticipated to grow from USD 31.41 billion in 2024 to USD 85.42 billion by 2037, registering a CAGR of around 8% during the forecast period, from 2025 through 2037.
North America industry is set to hold largest revenue share of 40% by 2037, impelled by growing food and beverage industry in the region.
The major players in the market include Biosensors International Group, Ltd., Pinnacle Technologies Inc., Ercon, Inc., Nova Biomedical, Molex LLC, TDK Corp., Bio-Rad Laboratories Inc., Medtronic, Abbott Laboratories, Zimmer & Peacock AS, Siemens Healthcare.
